Butyrate may enhance toxicological defence in primary, adenoma and tumor human colon cells by favourably modulating expression of glutathione S -transferases genes, an approach in nutrigenomics
Open Access
- 3 March 2005
- journal article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 26 (6) , 1064-1076
- https://doi.org/10.1093/carcin/bgi059
Abstract
Butyrate, formed by bacterial fermentation of plant foods, has been suggested to reduce colon cancer risks by suppressing the proliferation of tumor cells. In addition, butyrate has been shown to induce glutathione S-transferases (GSTs) in tumor cell lines, which may contribute to the detoxification of dietary carcinogens. We hypothesize that butyrate also affects biotransformation in non-transformed colon cells. Thus, we have investigated the gene expression of drug metabolism genes in primary human colon tissue, premalignant LT97 adenoma and HT29 tumor cells cultured in an appropriate medium±butyrate. A total of 96 drug metabolism genes (including 12 GSTs) spotted on cDNA macroarrays (Superarray®; n = 3) were hybridized with biotin-labeled cDNA probes. To validate the expression detected with Superarray®, samples of LT97 cells were also analyzed with high density microarrays (Affymetrix® U133A), which include biotransformation genes that overlap with the set of genes represented on the Superarray®. Relative expression levels were compared across colon samples and for each colon sample±butyrate. Compared with fresh tissue, 13 genes were downregulated in primary cells cultivated ex vivo, whereas 8 genes were upregulated. Several genes were less expressed in LT97 (40 genes) or in HT29 (41 and 17 genes, grown for 72 and 48 h, respectively) compared with primary colon tissue. Butyrate induced GSTP1, GSTM2, and GSTA4 in HT29 as previously confirmed by other methods (northern blot/qPCR). We detected an upregulation of GSTs (GSTA2, GSTT2) that are known to be involved in the defence against oxidative stress in primary cells upon incubation with butyrate. The changes in expression detected in LT97 by Superarray® and Affymetrix® were similar, confirming the validity of the results. We conclude that low GST expression levels were favourably altered by butyrate. An induction of the toxicological defence system possibly contributes to reported chemopreventive properties of butyrate, a product of dietary fibre fermentation in the gut.Keywords
This publication has 73 references indexed in Scilit:
- Cancer chemoprevention with dietary phytochemicalsNature Reviews Cancer, 2003
- Butyrate is only one of several growth inhibitors produced during gut flora-mediated fermentation of dietary fibre sourcesBritish Journal of Nutrition, 2003
- Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltiprazCarcinogenesis: Integrative Cancer Research, 2003
- Expression of glutathione S-transferases (GSTs) in human colon cells and inducibility of GSTM2 by butyrateCarcinogenesis: Integrative Cancer Research, 2003
- Chemoprevention of cancerCarcinogenesis: Integrative Cancer Research, 2000
- Wheat Bran Decreases Aberrant Crypt Foci, Preserves Normal Proliferation, and Increases Intraluminal Butyrate Levels in Experimental Colon CancerJournal of Parenteral and Enteral Nutrition, 1999
- Human glutathione transferase A4-4 crystal structures and mutagenesis reveal the basis of high catalytic efficiency with toxic lipid peroxidation productsJournal of Molecular Biology, 1999
- The redox-sensitive human antioxidant responsive element induces gene expression under low oxygen conditionsCarcinogenesis: Integrative Cancer Research, 1998
- cDNA Cloning of Murine Nrf 2 Gene, Coding for a p45 NF-E2-Related Transcription FactorBiochemical and Biophysical Research Communications, 1995
- Oltipraz: Clinical opportunities for cancer chemopreventionJournal of Cellular Biochemistry, 1995